Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ivermectin vs Malathion for Head Lice
NCT00819520Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2004
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of CHILD-IVITAB in pediculosis capitis (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Absence or presence of live head lice at Day 15. Started Feb 2004; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT00819520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819520.